Montesano M A, Freeman G L, Gazzinelli G, Colley D G
Universidade Federal de Juiz de Fora, MG, Brazil.
J Immunol. 1990 Nov 1;145(9):3095-9.
A monoclonal human anti-soluble schistosomal egg Ag(SEA) antibody (E5) that stimulates anti-Id T cells and is idiotypically represented in pools of immunoaffinity-purified human anti-SEA antibodies from chronic, generally asymptomatic, intestinal (INT) patients (AM1 and AM5) was used to raise several monoclonal anti-Id: 1C2, 1C6, 4A8, 4F9, and 2A7. Cross-inhibition between these anti-Id identified distinct idiotopes on E5. Anti-SEA preparations from schistosomiasis patients (AM1, AM5, and others) were tested for their inhibition of the E5/monoclonal anti-Id reactions, in competitive ELISA. In either the E5/4A8 or E5/1C6 ELISA system, anti-SEA from INT (AM1 or AM5) or hepatointestinal (HI) (AM7) patients were able to inhibit these reactions. However, anti-SEA antibodies from acute (AM9) or hepatosplenic (HS) (AM3 or AM8) patients did not express Id that were inhibitory in these systems. These results suggest that a relatively high proportion of INT and HI anti-SEA antibodies express a dominant cross-reactive idiotope (CRI) recognized by 1C6/4A8. This CRI is also easily detected in plasmas from individual INT patients. Anti-Id 1C2 reacted strongly with an Id in AM1, AM5, or AM7, but one which also occurred, to a lesser extent, in AM3, AM8, and AM9. Monoclonal anti-Id 4F9 and 2A7 reacted weakly with idiotopes expressed by antibodies from all patients, regardless of the clinical form of their infection. These observations indicate that anti-SEA antibodies from INT and HI, but not acute or HS patients express dominant, CRI that are identified by 1C6, 4A8, or 1C2 and are also expressed on the INT-derived anti-SEA mAb E5.
一种刺激抗独特型T细胞的人源单克隆抗可溶性血吸虫卵抗原(SEA)抗体(E5),其独特型表现在来自慢性、通常无症状的肠道(INT)患者(AM1和AM5)的免疫亲和纯化人抗SEA抗体池中,被用于制备几种单克隆抗独特型抗体:1C2、1C6、4A8、4F9和2A7。这些抗独特型抗体之间的交叉抑制确定了E5上不同的独特型表位。在竞争ELISA中,检测了血吸虫病患者(AM1、AM5等)的抗SEA制剂对E5/单克隆抗独特型抗体反应的抑制作用。在E5/4A8或E5/1C6 ELISA系统中,INT(AM1或AM5)或肝肠(HI)(AM7)患者的抗SEA能够抑制这些反应。然而,急性(AM9)或肝脾(HS)(AM3或AM8)患者的抗SEA抗体在这些系统中不表达具有抑制作用的独特型。这些结果表明,INT和HI抗SEA抗体中相对较高比例表达了被1C6/4A8识别的显性交叉反应独特型(CRI)。这种CRI在个体INT患者的血浆中也很容易检测到。抗独特型抗体1C2与AM1、AM5或AM7中的一种独特型强烈反应,但在AM3、AM8和AM9中也有程度较轻的反应。单克隆抗独特型抗体4F9和2A7与所有患者抗体表达的独特型表位反应较弱,无论其感染的临床类型如何。这些观察结果表明,INT和HI患者的抗SEA抗体,而非急性或HS患者的抗SEA抗体,表达了被1C6、4A8或1C2识别的显性CRI,并且也在INT来源的抗SEA单克隆抗体E5上表达。